DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
SUMANIROLE
3
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor agonist
SUMANIROLE
×
Maximum Phase:
3
First Approval:
None
UNII:
3E93IV1U45
Molecule Type:
Small molecule
Molecular Formula:
C11H13N3O
Molecular Weight:
203.25
AlogP:
0.47
PSA:
49.82
HBD:
2.0
HBA:
#RotB:
1.0
Source:
ZANDELISIB
3
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Neoplasms; Lymphoma, Follicular
PI3-kinase p110-delta subunit inhibitor
ZANDELISIB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C31H38F2N8O
Molecular Weight:
576.7
AlogP:
5.23
PSA:
84.23
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CS-3150
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CS-3150
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RUBELLA VIRUS VACCINE LIVE
3
Unknown
Investigational
Unknown
Unknown
Measles; Chickenpox; Meningococcal Infections
Unknown
RUBELLA VIRUS VACCINE LIVE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VOLANESORSEN
3
Oligonucleotide
Investigational
Unknown
Unknown
Lipodystrophy, Familial Partial; Hypertriglyceridemia
Apolipoprotein C-III mRNA 3'UTR antisense inhibitor
VOLANESORSEN
×
Maximum Phase:
3
First Approval:
None
UNII:
2O4BE0K238
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANTIVENIN (LATRODECTUS MACTANS)
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ANTIVENIN (LATRODECTUS MACTANS)
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYT387
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CYT387
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CLODRONIC ACID
3
Small molecule
Investigational
Unknown
Unknown
Bone Diseases; Brachial Plexus Neuropathies
Unknown
CLODRONIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
0813BZ6866
Molecule Type:
Small molecule
Molecular Formula:
CH4Cl2O6P2
Molecular Weight:
244.89
AlogP:
0.43
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
2.0
Source:
DEPEMOKIMAB
3
Antibody
Investigational
Unknown
Unknown
Asthma
Unknown
DEPEMOKIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VENGLUSTAT
3
Small molecule
Investigational
Unknown
Unknown
Fabry Disease; Gaucher Disease; Parkinson Disease; Polycystic Kidney, Autosomal Dominant; Kidney Diseases, Cystic
Unknown
VENGLUSTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
BLP1XA3FZA
Molecule Type:
Small molecule
Molecular Formula:
C20H24FN3O2S
Molecular Weight:
389.5
AlogP:
4.0
PSA:
54.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALANINE
3
Small molecule
Investigational
Unknown
Unknown
Asthma; Glioma; Coronary Disease
Unknown
ALANINE
×
Maximum Phase:
3
First Approval:
None
UNII:
1FU7983T0U
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
-0.58
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
RELAXIN
3
Unknown
Investigational
Unknown
Unknown
Pre-Eclampsia; Heart Failure; Scleroderma, Systemic
Unknown
RELAXIN
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SASANLIMAB
3
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Urinary Bladder Neoplasms
Programmed cell death protein 1 antagonist
SASANLIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
LZZ0IC2EWP
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NICOBOXIL
3
Small molecule
Investigational
Unknown
Unknown
Low Back Pain
Unknown
NICOBOXIL
×
Maximum Phase:
3
First Approval:
None
UNII:
GSD5B9US0W
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO3
Molecular Weight:
223.27
AlogP:
2.06
PSA:
48.42
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PROPIVERINE
3
Small molecule
Investigational
Unknown
Unknown
Urinary Bladder, Overactive; Polyuria; Urinary Incontinence
Unknown
PROPIVERINE
×
Maximum Phase:
3
First Approval:
None
UNII:
468GE2241L
Molecule Type:
Small molecule
Molecular Formula:
C23H29NO3
Molecular Weight:
367.49
AlogP:
3.99
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
7.0
Source:
NALFURAFINE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NALFURAFINE
×
Maximum Phase:
3
First Approval:
None
UNII:
XC41AVD567
Molecule Type:
Small molecule
Molecular Formula:
C28H32N2O5
Molecular Weight:
476.57
AlogP:
3.09
PSA:
86.38
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DAXIBOTULINUMTOXINA
3
Unknown
Investigational
Unknown
Unknown
Torticollis
Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
DAXIBOTULINUMTOXINA
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMSACRINE
3
Small molecule
Investigational
Unknown
Unknown
Leukemia; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
DNA topoisomerase II inhibitor
AMSACRINE
×
Maximum Phase:
3
First Approval:
None
UNII:
00DPD30SOY
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O3S
Molecular Weight:
393.47
AlogP:
4.51
PSA:
80.32
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FERRIC GLUCONATE TRIHYDRATE
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FERRIC GLUCONATE TRIHYDRATE
×
Maximum Phase:
3
First Approval:
None
UNII:
W108RK810P
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMENAMEVIR
3
Small molecule
Investigational
Unknown
Unknown
Herpes Genitalis; Herpes Simplex; Herpes Zoster; Virus Diseases
Helicase primate complex inhibitor
AMENAMEVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
94X46KW4AE
Molecule Type:
Small molecule
Molecular Formula:
C24H26N4O5S
Molecular Weight:
482.56
AlogP:
3.15
PSA:
122.47
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MIZORIBINE
3
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Lupus Nephritis; Nephrotic Syndrome
GMP synthase [glutamine-hydrolyzing] inhibitor
MIZORIBINE
×
Maximum Phase:
3
First Approval:
None
UNII:
4JR41A10VP
Molecule Type:
Small molecule
Molecular Formula:
C9H13N3O6
Molecular Weight:
259.22
AlogP:
-2.7
PSA:
151.06
HBD:
5.0
HBA:
#RotB:
3.0
Source:
HSK-3486
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases
GABA-A receptor; anion channel agonist
HSK-3486
×
Maximum Phase:
3
First Approval:
None
UNII:
M3WGS532VY
Molecule Type:
Small molecule
Molecular Formula:
C14H20O
Molecular Weight:
204.31
AlogP:
4.03
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CARBOXYAMIDOTRIAZOLE
3
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Gliosarcoma; Kidney Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung
Unknown
CARBOXYAMIDOTRIAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
6ST3ZF52WB
Molecule Type:
Small molecule
Molecular Formula:
C17H12Cl3N5O2
Molecular Weight:
424.68
AlogP:
3.2
PSA:
116.89
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PUTRESCINE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PUTRESCINE
×
Maximum Phase:
3
First Approval:
None
UNII:
V10TVZ52E4
Molecule Type:
Small molecule
Molecular Formula:
C4H12N2
Molecular Weight:
88.15
AlogP:
-0.32
PSA:
52.04
HBD:
2.0
HBA:
#RotB:
3.0
Source:
COSIBELIMAB
3
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung
Unknown
COSIBELIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
PNW7GBB44P
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZASITE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZASITE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PAFURAMIDINE MALEATE
3
Small molecule
Investigational
Unknown
Unknown
Malaria; Trypanosomiasis; Pneumonia, Pneumocystis
Kinetoplast DNA inhibitor
PAFURAMIDINE MALEATE
×
Maximum Phase:
3
First Approval:
None
UNII:
K27F04K3A9
Molecule Type:
Small molecule
Molecular Formula:
C24H24N4O7
Molecular Weight:
480.48
AlogP:
3.57
PSA:
103.36
HBD:
4.0
HBA:
#RotB:
6.0
Source:
WHEAT BRAN
3
Unknown
Investigational
Unknown
Unknown
Constipation
Unknown
WHEAT BRAN
×
Maximum Phase:
3
First Approval:
None
UNII:
6L966A1IMR
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OCIPERLIMAB
3
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Hepatocellular; Esophageal Neoplasms; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung
T-cell immunoreceptor with Ig and ITIM domains inhibitor
OCIPERLIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSGEMCITABINE PALABENAMIDE, P(RS)-
3
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Biliary Tract Neoplasms
Unknown
FOSGEMCITABINE PALABENAMIDE, P(RS)-
×
Maximum Phase:
3
First Approval:
None
UNII:
XCL1K2T28K
Molecule Type:
Small molecule
Molecular Formula:
C25H27F2N4O8P
Molecular Weight:
580.48
AlogP:
2.64
PSA:
164.23
HBD:
3.0
HBA:
#RotB:
11.0
Source:
METHYLTHIONINIUM
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
METHYLTHIONINIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROLUPERIDONE
3
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE
×
Maximum Phase:
3
First Approval:
None
UNII:
4P31I0M3BF
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN2O2
Molecular Weight:
366.44
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
COPPER OXODOTREOTIDE
3
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
COPPER OXODOTREOTIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C65H88CuN14O19S2
Molecular Weight:
1497.18
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
4-HYDROXYTAMOXIFEN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
4-HYDROXYTAMOXIFEN
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEURUXOLITINIB
3
Small molecule
Investigational
Unknown
Unknown
Alopecia Areata
Unknown
DEURUXOLITINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
0CA0VSF91Y
Molecule Type:
Small molecule
Molecular Formula:
C17H18N6
Molecular Weight:
314.42
AlogP:
3.47
PSA:
83.18
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
227
228
229
230
231
232
233
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA